Mutual of America Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.96M | Sell |
6,689
-278
| -4% | -$78.9K | 0.02% | 814 |
|
|
2026
Q1 | $1.94M | Sell |
6,967
-601
| -8% | -$173K | 0.02% | 778 |
|
|
2025
Q4 | $2.29M | Sell |
7,568
-863
| -10% | -$269K | 0.02% | 754 |
|
|
2025
Q3 | $2.36M | Sell |
8,431
-819
| -9% | -$223K | 0.02% | 759 |
|
|
2025
Q2 | $2.23M | Sell |
9,250
-667
| -7% | -$158K | 0.02% | 786 |
|
|
2025
Q1 | $2.42M | Sell |
9,917
-254
| -2% | -$76.4K | 0.03% | 752 |
|
|
2024
Q4 | $3.34M | Sell |
10,171
-177
| -2% | -$60.1K | 0.04% | 647 |
|
|
2024
Q3 | $3.46M | Buy |
10,348
+7,777
| +302% | +$2.47M | 0.04% | 657 |
|
|
2024
Q2 | $702K | Sell |
2,571
-170
| -6% | -$49.4K | 0.01% | 1083 |
|
|
2024
Q1 | $948K | Sell |
2,741
-57
| -2% | -$18.7K | 0.01% | 1050 |
|
|
2023
Q4 | $903K | Sell |
2,798
-123
| -4% | -$38.6K | 0.01% | 1055 |
|
|
2023
Q3 | $1.05M | Sell |
2,921
-148
| -5% | -$57.1K | 0.01% | 1034 |
|
|
2023
Q2 | $1.16M | Sell |
3,069
-9
| -0.3% | -$3.66K | 0.01% | 1029 |
|
|
2023
Q1 | $1.47M | Buy |
3,078
+6
| +0.2% | +$2.81K | 0.02% | 979 |
|
|
2022
Q4 | $1.29M | Buy |
3,072
+107
| +4% | +$43.2K | 0.02% | 1003 |
|
|
2022
Q3 | $1.24M | Buy |
2,965
+17
| +0.6% | +$8.48K | 0.02% | 994 |
|
|
2022
Q2 | $1.46M | Buy |
2,948
+67
| +2% | +$34.9K | 0.02% | 980 |
|
|
2022
Q1 | $1.62M | Buy |
2,881
+30
| +1% | +$18.1K | 0.02% | 999 |
|
|
2021
Q4 | $2.15M | Buy |
2,851
+33
| +1% | +$24.7K | 0.02% | 951 |
|
|
2021
Q3 | $2.1M | Buy |
2,818
+10
| +0.4% | +$7.49K | 0.02% | 937 |
|
|
2021
Q2 | $1.81M | Buy |
2,808
+39
| +1% | +$23.7K | 0.02% | 1003 |
|
|
2021
Q1 | $1.58M | Buy |
2,769
+54
| +2% | +$32K | 0.02% | 1026 |
|
|
2020
Q4 | $1.58M | Sell |
2,715
-75
| -3% | -$42.7K | 0.02% | 994 |
|
|
2020
Q3 | $1.44M | Sell |
2,790
-119
| -4% | -$60.3K | 0.02% | 953 |
|
|
2020
Q2 | $1.31M | Sell |
2,909
-17,187
| -86% | -$7.58M | 0.02% | 980 |
|
|
2020
Q1 | $7.04M | Buy |
20,096
+879
| +5% | +$323K | 0.12% | 182 |
|
|
2019
Q4 | $7.11M | Buy |
19,217
+57
| +0.3% | +$20.1K | 0.09% | 268 |
|
|
2019
Q3 | $6.38M | Buy |
19,160
+1,385
| +8% | +$452K | 0.09% | 278 |
|
|
2019
Q2 | $5.55M | Buy |
17,775
+37
| +0.2% | +$11.1K | 0.08% | 346 |
|
|
2019
Q1 | $5.42M | Buy |
17,738
+23
| +0.1% | +$6.21K | 0.08% | 344 |
|
|
2018
Q4 | $4.11M | Buy |
17,715
+1,188
| +7% | +$319K | 0.07% | 427 |
|
|
2018
Q3 | $5.17M | Sell |
16,527
-895
| -5% | -$278K | 0.07% | 393 |
|
|
2018
Q2 | $5.03M | Buy |
17,422
+839
| +5% | +$232K | 0.07% | 388 |
|
|
2018
Q1 | $4.15M | Sell |
16,583
-90
| -0.5% | -$22.9K | 0.06% | 482 |
|
|
2017
Q4 | $3.98M | Buy |
16,673
+241
| +1% | +$58.4K | 0.06% | 516 |
|
|
2017
Q3 | $3.65M | Sell |
16,432
-574
| -3% | -$129K | 0.06% | 530 |
|
|
2017
Q2 | $3.85M | Buy |
17,006
+144
| +0.9% | +$31.4K | 0.07% | 489 |
|
|
2017
Q1 | $3.36M | Buy |
16,862
+871
| +5% | +$168K | 0.06% | 542 |
|
|
2016
Q4 | $2.92M | Buy |
15,991
+373
| +2% | +$63.6K | 0.05% | 587 |
|
|
2016
Q3 | $2.56M | Buy |
15,618
+197
| +1% | +$29.9K | 0.05% | 611 |
|
|
2016
Q2 | $2.21M | Buy |
15,421
+887
| +6% | +$127K | 0.05% | 650 |
|
|
2016
Q1 | $1.99M | Buy |
14,534
+863
| +6% | +$113K | 0.04% | 669 |
|
|
2015
Q4 | $1.9M | Sell |
13,671
-98
| -0.7% | -$13.6K | 0.04% | 703 |
|
|
2015
Q3 | $1.85M | Buy |
13,769
+444
| +3% | +$63.9K | 0.04% | 696 |
|
|
2015
Q2 | $2.01M | Buy |
13,325
+3
| +0% | +$429 | 0.04% | 709 |
|
|
2015
Q1 | $1.8M | Buy |
13,322
+356
| +3% | +$44.1K | 0.04% | 765 |
|
|
2014
Q4 | $1.56M | Buy |
12,966
+213
| +2% | +$24.5K | 0.04% | 813 |
|
|
2014
Q3 | $1.45M | Buy |
12,753
+276
| +2% | +$32.7K | 0.03% | 836 |
|
|
2014
Q2 | $1.49M | Sell |
12,477
-106
| -0.8% | -$12.9K | 0.04% | 844 |
|
|
2014
Q1 | $1.61M | Buy |
12,583
+123
| +1% | +$15.8K | 0.04% | 787 |
|
|
2013
Q4 | $1.54M | Buy |
12,460
+75
| +0.6% | +$9.14K | 0.04% | 799 |
|
|
2013
Q3 | $1.46M | Buy |
12,385
+476
| +4% | +$56.1K | 0.04% | 773 |
|
|
2013
Q2 | $1.34M | Buy |
+11,909
| New | +$1.4M | 0.04% | 761 |
|
Other funds holding BIO
GKIM
Mutual of America Capital Management's BIO Position: Q2 2026 in Review
Mutual of America Capital Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 4% in Q2 2026, selling an estimated $78.9K and leaving 6,689 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #814.
Mutual of America Capital Management first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.11M in Q4 2019. 252 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Mutual of America Capital Management held 6,689 shares of Bio-Rad Laboratories Class A worth $1.96M as of Q2 2026.
- Mutual of America Capital Management sold 278 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $78.9K.
- Bio-Rad Laboratories Class A made up 0.02% of Mutual of America Capital Management's portfolio in Q2 2026, its #814 holding.
- Mutual of America Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
- Mutual of America Capital Management's Bio-Rad Laboratories Class A position peaked at $7.11M in Q4 2019.
- 252 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.